4.1 Article

Sarcopenia

期刊

CLINICS IN GERIATRIC MEDICINE
卷 33, 期 3, 页码 305-+

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cger.2017.02.003

关键词

Sarcopenia; Muscle mass; Sarcopenic obesity; Myostatin; Exercise; Selective androgen receptor agonist

向作者/读者索取更多资源

Sarcopenia refers to age-related muscle loss, defined using a combination of appendicular muscle mass, muscle strength, and physical performance measures. The pathogenesis depends on a balance between positive and negative regulators of muscle growth. Sarcopenia increases the risk for falls, fractures, dependency, use of hospital services, institutionalization, poor quality of life, and mortality. In clinical practice, brief screening tools, such as the 5-item SARC-F score, may be useful. Although pharmacologic treatments are actively being studied, the current mainstay consists of optimizing nutrition status, in particular protein and vitamin D status, and resistance exercises.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据